Georgia Clinical Research

Austell, Georgia 30106

0 studies enrolling now · 11 studies all time

What they study most

COPD, Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis, Lung Diseases, Obstructive, Pulmonary Arterial Hypertension, Pulmonary Disease, Chronic Obstructive, Pulmonary Hypertension

Studies at this site

• Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD) — Stopped early
• A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension — Running, not enrolling
• Selexipag (ACT-293987) in Pulmonary Arterial Hypertension — Completed
• A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD) — Stopped early
• Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis — Completed
• A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension — Stopped early
• Beraprost-314d Added-on to Tyvaso® (BEAT) — Completed
• Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument — Completed
• A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease — Completed
• Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema — Stopped early
• 26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed